p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
Saved in:
| Title: | p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis. |
|---|---|
| Authors: | Le Roux, Özgün1 (AUTHOR), Everitt, Jeffery I.2 (AUTHOR), Counter, Christopher M.1 (AUTHOR) count004@mc.duke.edu |
| Source: | PLoS ONE. 3/28/2024, Vol. 19 Issue 3, p1-12. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
